PubMed for id: 301674

Year	Number of Results
2000	1
2006	2
2008	1
2009	1
2011	1
2012	1
2014	1
2017	1
2018	2
2019	1
2020	2
2024	0

1

miR-324-5p upregulation potentiates resistance to cisplatin by targeting FBXO11 signalling in non-small cell lung cancer cells.

Ba Z, Zhou Y, Yang Z, Xu J, Zhang X. Ba Z, et al. J Biochem. 2019 Dec 1;166(6):517-527. doi: 10.1093/jb/mvz066. J Biochem. 2019. PMID: 31778188

2

Modulation of Ca²⁺-induced Ca²⁺ release by ubiquitin protein ligase E3 component n-recognin UBR3 and 6 in cardiac myocytes.

Ma XE, Liu B, Zhao CX. Ma XE, et al. Channels (Austin). 2020 Dec;14(1):326-335. doi: 10.1080/19336950.2020.1824957. Channels (Austin). 2020. PMID: 32988261 Free PMC article.

3

LINC01436, regulating miR-585 and FBXO11, is an oncogenic lncRNA in the progression of gastric cancer.

Zhang Y, Yang G, He X, Chen S, Zhang F, Fang X. Zhang Y, et al. Cell Biol Int. 2020 Mar;44(3):882-893. doi: 10.1002/cbin.11287. Epub 2020 Jan 8. Cell Biol Int. 2020. PMID: 31829474

4

F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.

Sun C, Tao Y, Gao Y, Xia Y, Liu Y, Wang G, Gu Y. Sun C, et al. Biomed Pharmacother. 2018 Feb;98:416-423. doi: 10.1016/j.biopha.2017.12.088. Epub 2017 Dec 27. Biomed Pharmacother. 2018. PMID: 29278851

5

A mutation in the F-box gene, Fbxo11, causes otitis media in the Jeff mouse.

Hardisty-Hughes RE, Tateossian H, Morse SA, Romero MR, Middleton A, Tymowska-Lalanne Z, Hunter AJ, Cheeseman M, Brown SD. Hardisty-Hughes RE, et al. Hum Mol Genet. 2006 Nov 15;15(22):3273-9. doi: 10.1093/hmg/ddl403. Epub 2006 Oct 11. Hum Mol Genet. 2006. PMID: 17035249

6

FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues.

Cook JR, Lee JH, Yang ZH, Krause CD, Herth N, Hoffmann R, Pestka S. Cook JR, et al. Biochem Biophys Res Commun. 2006 Apr 7;342(2):472-81. doi: 10.1016/j.bbrc.2006.01.167. Epub 2006 Feb 8. Biochem Biophys Res Commun. 2006. PMID: 16487488

7

The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells.

Ma Y, Deng F, Li P, Chen G, Tao Y, Wang H. Ma Y, et al. Biomed Pharmacother. 2018 May;101:648-655. doi: 10.1016/j.biopha.2018.02.118. Epub 2018 Mar 22. Biomed Pharmacother. 2018. PMID: 29518611

8

PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis.

Zheng H, Shen M, Zha YL, Li W, Wei Y, Blanco MA, Ren G, Zhou T, Storz P, Wang HY, Kang Y. Zheng H, et al. Cancer Cell. 2014 Sep 8;26(3):358-373. doi: 10.1016/j.ccr.2014.07.022. Cancer Cell. 2014. PMID: 25203322 Free PMC article.

9

FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas.

Duan S, Cermak L, Pagan JK, Rossi M, Martinengo C, di Celle PF, Chapuy B, Shipp M, Chiarle R, Pagano M. Duan S, et al. Nature. 2012 Jan 5;481(7379):90-3. doi: 10.1038/nature10688. Nature. 2012. PMID: 22113614 Free PMC article.

10

A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse.

Nolan PM, Peters J, Strivens M, Rogers D, Hagan J, Spurr N, Gray IC, Vizor L, Brooker D, Whitehill E, Washbourne R, Hough T, Greenaway S, Hewitt M, Liu X, McCormack S, Pickford K, Selley R, Wells C, Tymowska-Lalanne Z, Roby P, Glenister P, Thornton C, Thaung C, Stevenson JA, Arkell R, Mburu P, Hardisty R, Kiernan A, Erven A, Steel KP, Voegeling S, Guenet JL, Nickols C, Sadri R, Nasse M, Isaacs A, Davies K, Browne M, Fisher EM, Martin J, Rastan S, Brown SD, Hunter J. Nolan PM, et al. Nat Genet. 2000 Aug;25(4):440-3. doi: 10.1038/78140. Nat Genet. 2000. PMID: 10932191

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year